Baird Financial Group, Inc. Dexcom Inc Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 464,260 shares of DXCM stock, worth $37.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

464,260

Previous 914,553 49.24%

Holding current value

$37.4 Million

Previous $104 Million 69.99%

% of portfolio

0.06%

Previous 0.22%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $28.8 Million - $52.3 Million	-450,293 Reduced 49.24%	464,260 $31.1 Million
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $6.86 Million - $8.74 Million	-62,208 Reduced 6.37%	914,553 $104 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $1.53 Million - $1.87 Million	-13,372 Reduced 1.35%	976,761 $135 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $5.91 Million - $9.71 Million	78,239 Added 8.58%	990,133 $123 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $9.41 Million - $15.1 Million	109,397 Added 13.63%	911,894 $85.1 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $15 Million - $17.5 Million	133,299 Added 19.92%	802,497 $103 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $450,320 - $532,243	4,330 Added 0.65%	669,198 $77.7 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $2.98 Million - $3.68 Million	39,027 Added 6.07%	681,840 $54.9 Million
Q2 2022 Aug 08, 2022	BUY	$67.99 - $132.89 $32.9 Million - $64.4 Million	484,394 Added 305.77%	642,813 $47.9 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $372,462 - $515,461	3,959 Added 2.56%	158,419 $81 Million
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $7.13 Million - $8.95 Million	-54,939 Reduced 26.24%	154,460 $82.9 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $255,570 - $342,916	-2,395 Reduced 1.13%	209,399 $115 Million
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $5.41 Million - $7.2 Million	66,738 Added 46.01%	211,794 $90.4 Million
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $800,926 - $989,374	-9,446 Reduced 6.11%	145,056 $52.1 Million
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $535,626 - $717,601	-6,867 Reduced 4.26%	154,502 $57.1 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $504,197 - $596,263	-5,279 Reduced 3.17%	161,369 $66.5 Million
Q2 2020 Oct 22, 2020	SELL	$62.68 - $105.34 $3.07 Million - $5.16 Million	-48,937 Reduced 22.7%	166,648 $67.6 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $3.13 Million - $5.27 Million	-49,999 Reduced 18.83%	215,585 $47.2 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $2.34 Million - $3.7 Million	48,945 Added 22.59%	265,584 $71.5 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $7.93 Million - $12.4 Million	216,639 New	216,639 $47.4 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Dexcom Inc Transaction History